MM NM Flashcards
Bone marrow location
Skull
Clavicle
Sternum
Humerus
Pelvis
Femur
Vertebrae
Associated disease
Myelofibrosis
MM mechanism
Activate osteoclasts
Inhibit osteoblast
Bone resorption
Hypercalcemia
Presentation
Bone pain
Pathologic fracture
Beta2 microglobulin
M-protein IgG>IgA - - increase viscosity in eye and CNS - - visual impairment, hearing loss, dizziness
LDH
Spinal cord compression - - collapse of vertebral body in response to therapy
Immunodeficiency
MGUS
<10% plasma cells
Serum M-protein <3 g/dL
Normal bone on X-ray
Smoldering MM (stage IA)
> 10% plasma cells
Serum M-protein >3 g/dL or urine M-protein >1 g/dL
Single plasmacytoma
End organ damage CRAB
Calcium elevation
Renal insufficiency
Anemia
Bone abnormalities
MM characteristics
> 10% plasma cells or plasmacytoma
End organ damage
MM stage I lab
Hb >10 g/dL
Calcium <12 mg/dL
IgG <5 g/dL
IgA <3 g/dL
Urine M-protein < 4 g/24 h
MM stage IB
< 5 focal lesions >5 mm
On T1 MRI: micronodular or salt and pepper
MM stage III lab
Hb <8.5 g/dL
Calcium >12 mg/dL
IgG >7 g/dL
IgA >5 g/dL
Urine M-protein >12 g/24 h
MM stage II
5-20 focal lesions
On T1 MRI : contrast between vertebral bone marrow and disc
MM stage III
> 20 focal lesions
On T1 MRI : T1 signal less than disc
MM stage A
Creatinine <2 mg/dL
No extramedullary disease
MM stage B
Creatinine >2 mg/dL
Extramedullary disease
MGUS = monoclonal gammopathy of undetermined significance
Progression
Progression to MM 1% per year or Waldenstrom macroglobulinemia
Can progress to Primary Amyloidosis, CLL, lymphoma
MGBS
Macroglobulinemia of borderline significance
Higher risk of progression
10-30% plasma cells
SMM = smoldering MM
Asymptomatic (no end organ damage)
Higher risk of progression to MM
MM overview
Symptomatic
CRAB
Non-secretory - - no elevated M-protein
Micromolecular - - only light chains secreted
IgD MM
POEMS sy 1%
Polyneuropathy - symmetric, distal
Organomegaly
Endocrinopathy
M-protein
Skin changes + sclerotic bone lesions
Plasma cell leukemia
> 20% plasma cells